ArticlePloS one2026
Children with autism spectrum disorder and attention deficit hyperactivity disorder have evidence of sensory nerve degeneration.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An increasing body of evidence supports the role of altered sensory processing in autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD). This exploratory study undertook corneal confocal microscopy (CCM) to assess for differences in corneal nerve fiber density (CNFD), branch density (CNBD) and fiber length (CNFL) in relation to ASD severity in children with ASD+ADHD (n = 21), ASD (n = 6) and healthy controls (HC) (n = 15). CNBD was significantly lower in children with ASD+ADHD (P = 0.002) and ASD (P < 0.001) and CNFL was significantly lower in children with ASD (P = 0.02) compared to HC. However, CNFD (mean difference = 2.28, 95% CI [-5.84, 10.40], P > 0.99) CNBD (mean difference = 14.1, 95% CI [-8.22, 36.4], p = 0.37) and CNFL (mean difference = 2.46, 95% CI [-2.28, 7.20], p = 0.61) did not differ between ASD+ADHD and ASD. CNFD (P = 0.876), CNBD (P = 0.405) and CNFL (P = 0.606) did not correlate with the severity of ASD. Corneal confocal microscopy reveals sensory nerve degeneration in children with ASD+ADHD and ASD alone compared to controls. Larger studies integrating CCM with sensory and cognitive assessment are required to determine the utility of CCM as a clinical screening strategy for neurodegneration in ASD, ADHD and ASD-ADHD combined.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.